iRhythm Holdings (IRTC) Shareholder's Equity Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.09% |
| Dec 31, 2025 | -13.96% |
| Sep 30, 2025 | -20.13% |
| Jun 30, 2025 | -24.89% |
| Mar 31, 2025 | -29.26% |
| Dec 31, 2024 | -31.23% |
| Sep 30, 2024 | -37.63% |
| Jun 30, 2024 | -31.34% |
| Mar 31, 2024 | -33.68% |
| Dec 31, 2023 | -14.96% |
| Sep 30, 2023 | -13.07% |
| Jun 30, 2023 | 23.82% |
| Mar 31, 2023 | 21.08% |
| Dec 31, 2022 | 20.99% |
| Sep 30, 2022 | 18.83% |
| Jun 30, 2022 | 73.61% |
| Mar 31, 2022 | 72.56% |
| Dec 31, 2021 | 75.02% |
| Sep 30, 2021 | 67.27% |
| Jun 30, 2021 | 65.83% |
| Mar 31, 2021 | 62.27% |
| Dec 31, 2020 | 62.68% |
| Sep 30, 2020 | 57.65% |
| Jun 30, 2020 | 10.50% |
| Mar 31, 2020 | 11.85% |
| Dec 31, 2019 | 13.32% |
| Sep 30, 2019 | 47.98% |
| Dec 31, 2018 | 35.96% |